K232-1870 Screening compound: N'-cyclopentyl-N-[4-(6-hexyl-7-hydroxy-2-oxo-2H-chromen-3-yl)-1,3-thiazol-2-yl]butanediamide

K232-1870 Screening compound: N'-cyclopentyl-N-[4-(6-hexyl-7-hydroxy-2-oxo-2H-chromen-3-yl)-1,3-thiazol-2-yl]butanediamide
K232-1870 Screening compound: N'-cyclopentyl-N-[4-(6-hexyl-7-hydroxy-2-oxo-2H-chromen-3-yl)-1,3-thiazol-2-yl]butanediamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K232-1870
N'-cyclopentyl-N-[4-(6-hexyl-7-hydroxy-2-oxo-2H-chromen-3-yl)-1,3-thiazol-2-yl]butanediamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K232-1870

Molecular Formula

C27H33N3O5S (C27 H33 N3 O5 S)

Compound Name

N'-cyclopentyl-N-[4-(6-hexyl-7-hydroxy-2-oxo-2H-chromen-3-yl)-1,3-thiazol-2-yl]butanediamide

IUPAC name

N'-cyclopentyl-N-[4-(6-hexyl-7-hydroxy-2-oxo-2H-chromen-3-yl)-13-thiazol-2-yl]butanediamide

SMILES

CCCCCCc(c(O)c1)cc(C=C2c3csc(NC(CCC(NC4CCCC4)=O)=O)n3)c1OC2=O

InChI

InChI=1S/C27H33N3O5S/c1-2-3-4-5-8-17-13-18-14-20(26(34)35-23(18)15-22(17)31)21-16-36-27(29-21)30-25(33)12-11-24(32)28-19-9-6-7-10-19/h13-16,19,31H,2-12H2,1H3,(H,28,32)(H,29,30,33)

InChI Key

CFKCOJAWBDNMSB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15083150

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

511.64

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.164

Distribution Coefficient, logD

5.150

Water Solubility, LogSw

-4.77

Polar Surface Area

94.924

Acid Dissociation Constant (pKa)

8.90

Base Dissociation Constant (pKb)

6.33

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

48.10

K232-1870 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

Eccentric PPI Library (11937 compounds)

Hsp90-Targeted Library (11355 compounds)

PLpro Library (6343 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with K232-1870 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K232-1870?
Check Price and Availability of K232-1870, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K232-1870 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K232-1870
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K232-1870
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K232-1870 available by request